Review article · 2025 · Open access
Navigating PROTACs in Cancer Therapy: Advancements, Challenges, and Future Horizons
Food Science & Nutrition, 13(2), e70011 · Published 1 February 2025 · DOI 10.1002/fsn3.70011
In brief
“Navigating PROTACs in Cancer Therapy: Advancements, Challenges, and Future Horizons” is a 2025 review article by Saooda Ibrahim and 8 co-authors, published in Food Science & Nutrition. OpenAlex counts 30 citations as of 21 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Food Science & Nutrition.
- Citations
- 30
- Most cited in
- 2026 (20)
- Field-weighted impact
- 1.98
- References
- 171
- Authors
- 9
Abstract
Proteolysis Targeting Chimeras (PROTACs) have revolutionized cancer therapy by offering a selective and innovative approach to degrade key oncogenic proteins associated with various malignancies. These hybrid molecules exploit the ubiquitin-proteasome system, facilitating the degradation of target proteins through an event-driven mechanism, thereby overcoming drug resistance and enhancing selectivity. With diverse targets including androgen receptors, BTK, estrogen receptors, BET proteins, and BRAF, PROTACs offer a versatile strategy for personalized cancer treatment. Advantages of PROTACs over traditional small molecule inhibitors include their ability to operate at lower concentrations, catalyzing the degradation of multiple proteins of interest with reduced cytotoxicity. Notably, PROTACs address challenges associated with traditionally "undruggable" targets, expanding the therapeutic landscape of cancer therapy. Ongoing preclinical and clinical studies highlight the transformative potential of PROTACs, with promising results in prostate, breast, lung, melanoma, and colorectal cancers. Despite their potential, challenges persist in optimizing physicochemical properties and enhancing bioavailability. Further research is needed to refine PROTAC design and address complexities in molecule development. Nevertheless, the development of oral androgen receptor PROTACs represents a significant milestone, demonstrating the feasibility and efficacy of this innovative therapeutic approach. This review provides a comprehensive overview of PROTACs in cancer therapy, emphasizing their mechanism of action, advantages, and challenges. As PROTAC research progresses, continued exploration in both preclinical and clinical settings will be crucial to unlocking their full therapeutic potential and shaping the future of personalized cancer treatment.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ibrahim, S., Khan, M. U., Khurram, I., Rehman, R., Rauf, A., Ahmad, Z., Aljohani, A. S. M., Al Abdulmonem, W., & Quradha, M. M. (2025). Navigating PROTACs in Cancer Therapy: Advancements, Challenges, and Future Horizons. Food Science & Nutrition, 13(2), e70011. https://doi.org/10.1002/fsn3.70011
MLA 9
Ibrahim, Saooda, et al. “Navigating PROTACs in Cancer Therapy: Advancements, Challenges, and Future Horizons.” Food Science & Nutrition, vol. 13, no. 2, 2025, p. e70011. https://doi.org/10.1002/fsn3.70011.
Chicago
Ibrahim, Saooda, Muhammad Umer Khan, Iqra Khurram, Raima Rehman, Abdur Rauf, Zubair Ahmad, Abdullah S. M. Aljohani, Waleed Al Abdulmonem, and Mohammed Mansour Quradha. 2025. “Navigating PROTACs in Cancer Therapy: Advancements, Challenges, and Future Horizons.” Food Science & Nutrition 13 (2): e70011. https://doi.org/10.1002/fsn3.70011.
Harvard
Ibrahim, S. et al. (2025) ‘Navigating PROTACs in Cancer Therapy: Advancements, Challenges, and Future Horizons’, Food Science & Nutrition, 13(2), p. e70011. doi:10.1002/fsn3.70011.
IEEE
S. Ibrahim et al., “Navigating PROTACs in Cancer Therapy: Advancements, Challenges, and Future Horizons,” Food Science & Nutrition, vol. 13, no. 2, p. e70011, 2025, doi: 10.1002/fsn3.70011.
BibTeX
@article{ibrahim2025navigating,
title = {{Navigating PROTACs in Cancer Therapy: Advancements, Challenges, and Future Horizons}},
author = {Ibrahim, Saooda and Khan, Muhammad Umer and Khurram, Iqra and Rehman, Raima and Rauf, Abdur and Ahmad, Zubair and Aljohani, Abdullah S. M. and Al Abdulmonem, Waleed and Quradha, Mohammed Mansour},
journal = {Food Science \& Nutrition},
year = {2025},
volume = {13},
number = {2},
pages = {e70011},
doi = {10.1002/fsn3.70011},
url = {https://doi.org/10.1002/fsn3.70011}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- PROTACs
- cancer therapy
- protein degradation
- ubiquitin-proteasome system
- androgen receptor
- Bruton's tyrosine kinase
- estrogen receptor
- BET proteins
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Ibrahim, S., Khan, M. U., Khurram, I., Rehman, R., Rauf, A., Ahmad, Z., Aljohani, A. S. M., Al Abdulmonem, W., & Quradha, M. M. (2025). Navigating PROTACs in Cancer Therapy: Advancements, Challenges, and Future Horizons. Food Science & Nutrition, 13(2), e70011. https://doi.org/10.1002/fsn3.70011
How many times has this paper been cited?
30 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Food Science & Nutrition: sign in and open the PDF from this page.
Who wrote this paper?
Saooda Ibrahim, Muhammad Umer Khan, Iqra Khurram, Raima Rehman, Abdur Rauf, Zubair Ahmad, Abdullah S. M. Aljohani, Waleed Al Abdulmonem, Mohammed Mansour Quradha.
What is the DOI of this paper?
10.1002/fsn3.70011, permanently at https://doi.org/10.1002/fsn3.70011. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.